NASDAQ: FATEFate Therapeutics Inc Stock Forecast, Predictions & Price Target
Analyst price target for FATE
Based on 9 analysts offering 12 month price targets for Fate Therapeutics Inc.
Min Forecast
$5.00+147.52%
Avg Forecast
$6.27+210.25%
Max Forecast
$10.00+395.05%
Should I buy or sell FATE stock?
Based on 9 analysts offering ratings for Fate Therapeutics Inc.
Buy
Strong Buy
2 analysts 22.22%
Buy
0 analysts 0%
Hold
7 analysts 77.78%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Be the first to know when Wall Street analysts revise their FATE stock forecasts and price targets.
FATE stock forecasts by analyst
| Analyst / Firm | Rating | Action | Price Target | Upside/Downside | Date | Analyst Color |
|---|---|---|---|---|---|---|
| Hold | Reiterates | $5.00 | +147.52% | 2023-09-07 | ||
| Hold | Reiterates | $7.00 | +246.53% | 2023-08-16 | ||
| Hold | Maintains | $5.00 | +147.52% | 2023-08-10 | ||
| Strong Buy | Maintains | $6.00 | +197.03% | 2023-08-10 | ||
| Hold | Maintains | $5.40 | +167.33% | 2023-08-09 | ||
| Strong Buy | Reiterates | $10.00 | +395.05% | 2023-08-09 | ||
| Hold | Reiterates | $7.00 | +246.53% | 2023-05-05 | ||
| Hold | Maintains | $5.00 | +147.52% | 2023-05-04 | ||
| Hold | Assumes | $6.00 | +197.03% | 2023-03-27 |
Forecast return on equity
Is FATE forecast to generate an efficient return?
Company
N/A
Industry
0.6%
Market
28.78%
Forecast return on assets
Is FATE forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.1%
FATE revenue growth forecast
How is FATE forecast to perform vs Biotechnology companies and vs the US market?
Company
6.74%
Industry
35.17%
Market
8.14%
FATE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FATE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast
FATE vs Biotech Stocks
Fate Therapeutics Stock Forecast FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.